Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-05-31
2005-05-31
Pryor, Alton (Department: 1616)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
active
06900195
ABSTRACT:
A method of treating an infectious disease or condition in a subject in need of such treatment is disclosed. The method comprises administering to a subject an effective amount of a manzamine, manzamine derivative or analog or an optical isomer or racemate or tautomer thereof or a pharmaceutically acceptable salt thereof.
REFERENCES:
patent: 6143756 (2000-11-01), Kara et al.
El-Sayed Khalid
Hamann Mark T.
Greenberg & Traurig, LLP
Pryor Alton
Rzucidlo Eugene C.
The University of Mississippi
LandOfFree
Manzamines for treatment of drug resistant infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Manzamines for treatment of drug resistant infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Manzamines for treatment of drug resistant infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3370810